DE2166716C3 - Opiumalkaloid-Antigene und Verfahren zu ihrer Herstellung - Google Patents
Opiumalkaloid-Antigene und Verfahren zu ihrer HerstellungInfo
- Publication number
- DE2166716C3 DE2166716C3 DE2166716A DE2166716A DE2166716C3 DE 2166716 C3 DE2166716 C3 DE 2166716C3 DE 2166716 A DE2166716 A DE 2166716A DE 2166716 A DE2166716 A DE 2166716A DE 2166716 C3 DE2166716 C3 DE 2166716C3
- Authority
- DE
- Germany
- Prior art keywords
- opium alkaloid
- protein
- opium
- alkaloid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3699970A | 1970-05-13 | 1970-05-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2166716A1 DE2166716A1 (de) | 1975-04-24 |
| DE2166716B2 DE2166716B2 (de) | 1979-09-27 |
| DE2166716C3 true DE2166716C3 (de) | 1980-06-12 |
Family
ID=21891894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2166716A Expired DE2166716C3 (de) | 1970-05-13 | 1971-05-11 | Opiumalkaloid-Antigene und Verfahren zu ihrer Herstellung |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA966778A (enExample) |
| DE (1) | DE2166716C3 (enExample) |
| DK (1) | DK142145B (enExample) |
| GB (1) | GB1320056A (enExample) |
| SE (4) | SE389739B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104367A (en) * | 1976-10-13 | 1978-08-01 | Hoffmann-La Roche Inc. | Radioimmunoassay for methadone |
| CN113968853B (zh) * | 2020-07-22 | 2022-09-16 | 中国农业大学 | 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用 |
-
1971
- 1971-05-11 DE DE2166716A patent/DE2166716C3/de not_active Expired
- 1971-05-12 CA CA112,764A patent/CA966778A/en not_active Expired
- 1971-05-12 DK DK228271AA patent/DK142145B/da unknown
- 1971-05-13 SE SE7408141A patent/SE389739B/xx not_active IP Right Cessation
- 1971-05-13 SE SE7106271A patent/SE389737B/xx unknown
- 1971-05-13 GB GB1462971*[A patent/GB1320056A/en not_active Expired
-
1974
- 1974-06-19 SE SE7408141A patent/SE7408141L/xx unknown
- 1974-06-19 SE SE7408140A patent/SE417970B/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7408140L (enExample) | 1974-06-19 |
| DE2123300A1 (de) | 1971-11-25 |
| DE2166716A1 (de) | 1975-04-24 |
| CA966778A (en) | 1975-04-29 |
| DE2123300B2 (de) | 1976-03-04 |
| SE389739B (sv) | 1976-11-15 |
| SE7408141L (enExample) | 1974-06-19 |
| DE2166716B2 (de) | 1979-09-27 |
| SE389737B (sv) | 1976-11-15 |
| DK142145C (enExample) | 1981-02-02 |
| SE417970B (sv) | 1981-04-27 |
| GB1320056A (en) | 1973-06-13 |
| DK142145B (da) | 1980-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2202441C3 (enExample) | ||
| US3775536A (en) | Opium alkaloid antigens and antibodies specific therefor | |
| DE2806146C2 (de) | Tumor-spezifisches Glykoprotein und dessen Verwendung zur Krebsdiagnose beim Menschen | |
| DE69113114T2 (de) | Test für Phencyclidin und Phencyclidin-Metaboliten, Tracer, Immunogene, Antikörper und Reagenzsatz dafür. | |
| DE2805663C3 (enExample) | ||
| DE2816841A1 (de) | Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii) | |
| DE1598945B2 (de) | Verfahren zur bestimmung von proteinen und polypeptiden | |
| EP0013930B1 (de) | Immunogen, Antikörper für ein Thymus-Hormon, markiertes Thymus-Hormon und Verfahren zur Bestimmung dieses Thymushormons | |
| DE2716536C2 (de) | Methadon-Antigene und Verfahren zur Herstellung dieser | |
| DE69922990T2 (de) | Herstellungsverfahren von festphasekonjugateimpfstoffen | |
| DE2548196C2 (de) | Antigene auf Basis von Methaqualon- Hapten sowie deren Verwendung | |
| EP0183901B1 (de) | Bifunktionelle Haptene, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2842612A1 (de) | Antigen fuer die schwangerschaftsfruehbestimmung und schwangerschaftsverhuetende vaccine | |
| DE60035267T2 (de) | Verfahren zur analyse der menge an intraabdominalem fettgewebe | |
| DE2310280A1 (de) | Tubocurarin-antigene | |
| DE2166716C3 (de) | Opiumalkaloid-Antigene und Verfahren zu ihrer Herstellung | |
| EP0124779A2 (de) | Radioimmunverfahren für Thymosin beta 4 | |
| DE2738156A1 (de) | Bestimmung von catecholaminen | |
| DE2714751A1 (de) | Herstellung von alpha-l-antikoerpern, reinigung von alpha-l-antigenen und reagenz fuer die bestimmung von alpha-l-antikoerpern und alpha-l-antigenen | |
| DE2123300C3 (de) | Reagenz und Verfahren zur Bestimmung von Opiumalkaloiden | |
| DE69902419T2 (de) | Farbstoff-markierte Proteinkonjugat und Verfahren zu seiner Herstellung | |
| DE2905883A1 (de) | Radioimmuntest fuer clonidin | |
| DE2800783A1 (de) | Bestimmung von cholecalciferol | |
| DE2126128A1 (de) | Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens | |
| DE2739038A1 (de) | Klonidin-test |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |